In8bio Inc Stock Analysis

In8bio Stock Analysis Notes

About 22.0% of the company shares are held by company insiders. The book value of In8bio was currently reported as 0.58. The company recorded a loss per share of 0.74. In8bio Inc had not issued any dividends in recent years. IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. In8Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people. To learn more about In8bio Inc call the company at 646 600 6438 or check out https://in8bio.com.

In8bio Inc Investment Alerts

In8bio Inc Upcoming and Recent Events

In8bio Largest EPS Surprises

View All Earnings Estimates

In8bio Stock Institutional Investors

Note, although In8bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

In8bio Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.27 M.

In8bio Profitablity

Management Efficiency

In8bio Inc has return on total asset (ROA) of (0.7764) % which means that it has lost $0.7764 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8045) %, meaning that it created substantial loss on money invested by shareholders. In8bio's management efficiency ratios could be used to measure how well In8bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 13, 2024, Return On Tangible Assets is expected to decline to -0.93. In addition to that, Return On Capital Employed is expected to decline to -1.12. At present, In8bio's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 687.7 K, whereas Total Assets are forecasted to decline to about 25.1 M.

Technical Drivers

As of the 13th of December 2024, In8bio owns the Semi Deviation of 6.56, market risk adjusted performance of (0.16), and Standard Deviation of 12.32. In8bio Inc technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.

In8bio Inc Price Movement Analysis

In8bio Inc Insider Trading Activities

In8bio Outstanding Bonds

In8bio Predictive Daily Indicators

In8bio Forecast Models

In8bio's time-series forecasting models are one of many In8bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary In8bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how In8bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling In8bio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as In8bio. By using and applying In8bio Stock analysis, traders can create a robust methodology for identifying In8bio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. In8bio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. In8bio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

In8bio Inc stock analysis indicators help investors evaluate how In8bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading In8bio shares will generate the highest return on investment. By understating and applying In8bio stock analysis, traders can identify In8bio position entry and exit signals to maximize returns.

When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.